Possible entry level $9.80 = Target price $11.00 = Stop loss $9.50. Huge momentum swing in Teva, earnings may have been a disappointment but guidance and outlook turned investors bullish and may be a sign of a bottom in for the stock. The stock is now above its average analysts price target of $8.88 so they will forced to regrade the stock, hopefully bullishly. Alert set for break above 70 on the RSI